Multi-site Study of Rapid Diagnostic Syphilis Assays

Sponsor
Centers for Disease Control and Prevention (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00300534
Collaborator
(none)
1,000
5
1
83
200
2.4

Study Details

Study Description

Brief Summary

The performance of an investigational immunochromatographic strip (ICS) test for the diagnosis of syphilis is compared with the Abbott Laboratories Determine ICS test. The study population consists of patients with and without syphilis presenting to sexually transmitted disease clinics in five cities in the United States. Specimens include finger-stick whole blood (investigational test only) and whole blood, plasma, and serum by venipuncture.

Condition or Disease Intervention/Treatment Phase
  • Device: Abbott Laboratories Determine test for syphilis
  • Device: Investigational syphilis immunochromatographic strip test
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1000 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Multi-site Study of Rapid Diagnostic Syphilis Assays of Persons Attending STD Clinics in High Syphilis Morbidity Areas
Study Start Date :
Aug 1, 2002
Actual Primary Completion Date :
Dec 1, 2005
Actual Study Completion Date :
Jul 1, 2009

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Abbott Laboratories Determine test for syphilis

Abbott Laboratories Determine rapid test for syphilis

Device: Abbott Laboratories Determine test for syphilis

Device: Investigational syphilis immunochromatographic strip test

Outcome Measures

Primary Outcome Measures

  1. Diagnosis of Treponema pallidum infection [7 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Consecutive patients
Exclusion Criteria:
  • Less than age 18 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Los Angeles Department of Health Services Los Angeles California United States
2 Fulton County Department of Health Atlanta Georgia United States
3 Chicago Department of Public Health Chicago Illinois United States 60616
4 Bell Flower Clinic Indianapolis Indiana United States 46202
5 New York City Department of Health New York City New York United States

Sponsors and Collaborators

  • Centers for Disease Control and Prevention

Investigators

  • Principal Investigator: Robert E. Johnson, MD, MPH, Centers for Disease Control and Prevention

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00300534
Other Study ID Numbers:
  • CDC-NCHSTP-2875
First Posted:
Mar 9, 2006
Last Update Posted:
Sep 7, 2012
Last Verified:
Sep 1, 2012
Keywords provided by Centers for Disease Control and Prevention
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 7, 2012